| Epitope editing enables targeted immunotherapy of acute myeloid leukaemia G Casirati, A Cosentino, A Mucci, M Salah Mahmoud, I Ugarte Zabala, ... Nature 621 (7978), 404-414, 2023 | 55 | 2023 |
| Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia MM Naldini, G Casirati, M Barcella, PMV Rancoita, A Cosentino, ... Nature communications 14 (1), 1285, 2023 | 43 | 2023 |
| Curing hemoglobinopathies: challenges and advances of conventional and new gene therapy approaches I Motta, V Ghiaccio, A Cosentino, L Breda Mediterranean Journal of Hematology and Infectious Diseases 11 (1), e2019067, 2019 | 23 | 2019 |
| Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism S Levesque, A Cosentino, A Verma, P Genovese, DE Bauer Nature Biotechnology, 1-5, 2024 | 6 | 2024 |
| Epitope Engineered Hematopoietic Stem and Progenitor Cells to Enable CAR-T Cell Immunotherapy for Acute Myeloid Leukemia G Casirati, A Cosentino, A Mucci, IU Zabala, MS Mahmoud, C Brendel, ... American Society of Hematology Annual Meeting, 303-304, 2022 | 1 | 2022 |
| Epitope Editing Combined with Extended Schedule Anti-KIT Antibody Treatment Allows Immune-Based In Vivo Selection of Multiplex Genome-Engineered Cells G Casirati, A Mucci, M Freschi, A Cosentino, MS Mahmoud, J Zeng, ... Blood 144, 4767, 2024 | | 2024 |
| Abstract NG05: Epitope editing enables targeted immunotherapy of acute myeloid leukemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, IU Zabala, J Zeng, ... Cancer Research 84 (7_Supplement), NG05-NG05, 2024 | | 2024 |
| Epitope Edited Hematopoietic Stem Cells to Enable Synergistic Immunotherapy Combinations for Acute Myeloid Leukemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, IU Zabala, J Zeng, ... Blood 142, 7130, 2023 | | 2023 |
| Epitope Edited Hematopoietic Stem Cells Allow Immune-Based In Vivo Selection of Genome-Engineered Cells G Casirati, A Cosentino, A Mucci, MS Mahmoud, M Freschi, J Zeng, ... Blood 142, 7127, 2023 | | 2023 |
| 237 Epitope engineered hematopoietic stem cells to enable multi-specificity CAR-T cells for acute myeloid leukemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, IU Zabala, J Zeng, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| ENGINEERING IMMUNOTHERAPY RESISTANT HEMATOPOIESIS TO TREAT HIGH-RISK ACUTE MYELOID LEUKEMIA G Casirati, A Cosentino, L Sereni, V Cinella, A Mucci, C Brendel, ... HUMAN GENE THERAPY 33 (7-8), A8-A8, 2022 | | 2022 |
